Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.70    0.00 (0.00%)
Bid:
0.65
Ask:
0.75
Spread: 0.10 (15.385%)
Market Cap: £3.13m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Half year trading update and Board changes

14 Oct 2024 07:00

RNS Number : 9745H
Thruvision Group PLC
14 October 2024
 

14 October 2024

Thruvision Group plc

Half year trading update and Board changes

 

Thruvision (AIM: THRU, "Thruvision" or the "Group"), the leading international provider of walk-through security technology, today publishes a trading update for the six months ended 30 September 2024 ("H1 2025") and announces changes to the Board.

H1 Trading

Revenue is expected to be £1.9 million (H1 2024: £3.5 million). The current order backlog is £0.3 million and is forecast to be delivered during the second half of the year (H1 2024: £1.0 million). The sales pipeline contains significant tenders, some of which are expected to contribute to second half revenues.

Cash at 30 September 2024 was £1.8 million (30 September 2023: £2.4 million) and trade receivables were £0.9 million (30 September 2023: £2.6 million). The Group has an undrawn overdraft facility of £0.95 million available for working capital requirements.

In line with the Group's previously announced strategy, we now have approximately 85% of revenue in the period deriving from Retail Distribution sales, which doubled relative to the comparable period, and alongside healthy levels of repeat business, included orders from new customers John Lewis and DP World.

This was offset by the absence of any material Customs orders, whereas the comparable period benefitted from a single £1.9 million order from an Asian Customs agency. In Aviation, we achieved our first sale for aviation worker screening to a US regional airport since the Transportation Security Administration (TSA) issued its National Mandate on the subject, and customer interest levels remain elevated in this arena.

Outlook

Looking forward, we have a healthy pipeline across all our markets, with particularly significant near-term opportunities in Entrance Security and Retail Distribution. We are also seeing growth in our sales pipeline resulting from our recently signed channel partnership with Sensormatic, in particular, adding many opportunities across Europe. We intend to sign additional major channel partners in the future.

Besides the steady growth in smaller orders which characterised the first half, we are actively pursuing a number of very significant opportunities, any of which could materially extend our order backlog. Full year revenue will be dependent upon the timing of significant contract awards, which is unpredictable. However, inventory lead times mean that there is likely to be a modest slippage of revenue into the next financial year, such that the Board now expects revenue for the full year ending 31 March 2025 to be approximately £9 million (FY24: £7.8 million).

Board Changes

Colin Evans, the Group's CEO, has informed the Board that he wishes to leave the Group to further his non-executive directorship portfolio and, following discussion with the Board, he will leave the business at the end of October 2024.

Tom Black will take up the role of Executive Chairman and will manage the Group on a day-to-day basis until a permanent replacement can be appointed.

Tom Black, Executive Chairman, commented:

"It is gratifying to see good progress in Retail Distribution which has the potential to be our largest single market, but the overall reduction in revenues is disappointing. That said, our revenue base now derives from a broader range of customers which should smooth revenue volatility going forward.

"Much effort has been expended to enhance our sales capability in the past year, including new sales partnerships. We are encouraged by the quality of our pipeline, which contains a number of material opportunities, any one of which could be transformational. Converting these to revenue in a timely manner is our number one priority.

"Finally, I would like to thank Colin Evans for his enormous contribution to Thruvision over the past seven years, he has built a strong platform upon which we can now capitalise as we seek to convert these significant growth opportunities. We are sorry to see him go and wish him well for the future."

Interim Results

The Group intends to publish its Interim Results on 24 October 2024.

 

For further information, please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Executive Chairman

Victoria Balchin, Chief Financial Officer

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

Meare Consulting

Adrian Duffield +44 (0) 7990 858548

 

 

About Thruvision (www.thruvision.com)

Thruvision is the leading developer, manufacturer and supplier of advanced AI-based walk-through security technology internationally. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using advanced AI-based detection algorithms.

The Group's offices are near Oxford and Washington DC.

 

Important information

This announcement may include statements that are, or may be deemed to be, 'forward-looking statements' (including words such as 'believe', 'expect', 'estimate', 'intend', 'anticipate' and words of similar meaning). By their nature, forward-looking statements involve risk and uncertainty since they relate to future events and circumstances, and actual results may, and often do, differ materially from any forward-looking statements. Any forward-looking statements in this announcement reflect management's view with respect to future events as at the date of this announcement. Save as required by applicable law, the Company undertakes no obligation to publicly revise any forward-looking statements in this announcement, whether following any change in its expectations or to reflect events or circumstances after the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKNBPKBDBPKD
Date   Source Headline
8th Jun 20207:00 amRNSResults for the Year ended 31 March 2020
3rd Jun 20207:22 amRNSNotice of Annual Results
3rd Jun 20207:00 amRNSNotice of Annual Results
2nd Apr 20207:40 amRNSTrading Statement
25th Nov 20197:00 amRNSInterim Results
19th Nov 20197:00 amRNSNotice of Interim Results
13th Nov 20193:28 pmRNSHolding(s) in Company
24th Oct 20197:00 amRNSSharesave option grant to Executive Director
8th Oct 20192:00 pmRNSAward of Share Options to Executive Directors
3rd Oct 20197:00 amRNSTrading Update
23rd Sep 20191:29 pmRNSResult of Annual General Meeting
23rd Sep 20197:00 amRNSContract award announcement
16th Sep 20193:36 pmRNSThruvision trialed in London Underground station
8th Jul 20192:14 pmRNSNotice of Audited Results
24th Jun 20197:00 amRNSResults for the Year ended 31 March 2019
20th Jun 20197:00 amRNSNotice of Results
22nd May 20197:00 amRNSContract award announcement
1st May 20197:00 amRNSAppointment of Finance Director
2nd Apr 20197:00 amRNSPre-close Trading Update
7th Feb 20197:00 amRNSCapital Markets Day
18th Jan 20194:02 pmRNSAward of Share Options to Executive Directors
10th Dec 20187:00 amRNSInterim Results
3rd Dec 201812:52 pmRNSNotice of Results
2nd Nov 20181:24 pmRNSTSA Concept of Operations Development Contract
3rd Oct 20187:00 amRNSTrading Update
21st Sep 20183:57 pmRNSSharesave option grant to Executive Directors
21st Sep 201810:21 amRNSAGM Statement
7th Sep 20185:10 pmRNSHolding(s) in Company
7th Sep 20185:07 pmRNSHolding(s) in Company
24th Aug 20189:19 amRNSAmendment - Holding(s) in Company
22nd Aug 201811:30 amRNSHolding(s) in Company
21st Aug 201810:52 amRNSHolding(s) in Company
20th Aug 20183:04 pmRNSHolding(s) in Company
20th Aug 20182:53 pmRNSHolding(s) in Company
9th Aug 201812:30 pmRNSAnnouncement of Results of Tender Offer
31st Jul 20189:00 amRNSHolding(s) in Company
24th Jul 201810:21 amRNSResults of General Meeting/Tender Offer
4th Jul 20187:00 amRNSProposed Tender Offer & Notice of General Meeting
26th Jun 20187:00 amRNSAudited results for the full year 31 March 2018
21st Jun 201811:26 amRNSNotice of Audited Results
1st May 20183:53 pmRNSCapital Reduction Effective
28th Mar 20183:25 pmRNSResult of General Meeting
15th Mar 20185:13 pmRNSHolding(s) in Company
15th Mar 20182:00 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAward of Share Options to Executive Director
13th Mar 20185:29 pmRNSHolding(s) in Company
13th Mar 20183:40 pmRNSHolding(s) in Company
13th Mar 20183:17 pmRNSHolding(s) in Company
12th Mar 20182:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.